Amitriptyline Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care
DiscussionDetermining the clinical and cost-effectiveness of low-dose amitriptyline as a second-line treatment for IBS in primary care will provide robust evidence to inform management decisions.Trial registrationISRCTN ISRCTN48075063 . Registered on 7th June 2019. (Source: Trials)
Source: Trials - July 8, 2022 Category: Research Source Type: clinical trials

EA for BPS: An RCT and Study for Central Mechanism
Condition:   Bladder Pain Syndrome Interventions:   Procedure: electroacupuncture;   Drug: Amitriptyline;   Procedure: sham electroacupuncture Sponsor:   The Third Affiliated hospital of Zhejiang Chinese Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2022 Category: Research Source Type: clinical trials